Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. Among its listed roles, it functions as a antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include 9-Nitrocamptothecin and Orathecin. Its PubChem CID is 472335.
Rubitecan
| CAS No | 91421-42-0 |
|---|---|
| Molecular Formula | C20H15N3O6 |
| Molecular Weight | 393.3 g/mol |
| Synonyms | (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin.
The listed CAS number is 91421-42-0.
The listed molecular formula is C20H15N3O6.
The listed molecular weight is 393.3 g/mol.
(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione.
The source lists 9-Nitrocamptothecin and Orathecin.